Literature DB >> 15332708

PER-1 production in a urinary isolate of Providencia rettgeri.

G Bahar1, B Eraç, A Mert, Z Gülay.   

Abstract

A Providencia rettgeri strain resistant to extended-spectrum cephalosporins and intermediate to aztreonam was isolated from the urine of a patient hospitalized in the urology clinic of SSK Educational Hospital in Ankara. Clavulanic acid restored the activity of extended-spectrum cephalosporins, suggesting that the strain was harboring an extended-spectrum beta-lactamase. Since the PER-1 enzyme is widespread in Turkey, and had been already detected in a related species such as Proteus mirabilis, the Providencia strain was suspected of harboring a PER-1 enzyme, which was indeed detected by PCR. This is the first description in a P. rettgeri isolate of a PER-1 enzyme which is widespread among Acinetobacter baumanni and Pseudomonas aeruginosa strains in Turkey.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15332708     DOI: 10.1179/joc.2004.16.4.343

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  10 in total

1.  Tn5393d, a complex Tn5393 derivative carrying the PER-1 extended-spectrum beta-lactamase gene and other resistance determinants.

Authors:  Elisabetta Mantengoli; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Transposition of Tn1213 Encoding the PER-1 Extended-Spectrum β-Lactamase.

Authors:  Stefano Mancini; Laurent Poirel; Nicolas Kieffer; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  Interspecies dissemination of the bla gene encoding PER-1 extended-spectrum β-lactamase.

Authors:  Il Kwon Bae; Sook Jin Jang; Juwon Kim; Seok Hoon Jeong; Byungkyu Cho; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-12-13       Impact factor: 5.191

4.  Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria.

Authors:  Laurent Poirel; Ludovic Cabanne; Haluk Vahaboglu; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex.

Authors:  Joanna Empel; Krzysztof Filczak; Agnieszka Mrówka; Waleria Hryniewicz; David M Livermore; Marek Gniadkowski
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

6.  Molecular epidemiology of PER-1 extended spectrum beta-lactamase among gram-negative bacteria isolated at a tertiary care hospital.

Authors:  B Eraç; Z Gülay
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

7.  Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase.

Authors:  Andrea Endimiani; Francesco Luzzaro; Beatrice Pini; Gianfranco Amicosante; Gian Maria Rossolini; Antonio Q Toniolo
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

8.  Detection of blaPER-1 & blaOxa10 among imipenem resistant isolates of Pseudomonas aeruginosa isolated from burn patients hospitalized in Shiraz Burn Hospital.

Authors:  Amir Emami; Abdollah Bazargani; Ali Akbar Mohammadi; Mitra Zardosht; Seyed Morteza Seyed Jafari
Journal:  Iran J Microbiol       Date:  2015-02

9.  Emergence of multidrug-resistant Providencia rettgeri isolates co-producing NDM-1 carbapenemase and PER-1 extended-spectrum β-lactamase causing a first outbreak in Korea.

Authors:  Saeam Shin; Seok Hoon Jeong; Hyukmin Lee; Jun Sung Hong; Min-Jeong Park; Wonkeun Song
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-05-05       Impact factor: 3.944

Review 10.  Genetics of Acquired Antibiotic Resistance Genes in Proteus spp.

Authors:  Delphine Girlich; Rémy A Bonnin; Laurent Dortet; Thierry Naas
Journal:  Front Microbiol       Date:  2020-02-21       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.